Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes Three RNAi-Related Patent Applications: Mar 6, 2008

Premium
Title: Genetic Inhibition by Double-Stranded RNA
 
Number: 20080050342
 
Filed: July 13, 2007
 
Lead Inventor: Andrew Fire, Carnegie Institution
 
The patent application, its abstract states, claims a process of “introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical,” the abstract adds. The invention “is distinguished from prior art interference in gene expression by antisense or triple-strand methods.”
 

 
Title: Methods and Compositions Involving miRNA and miRNA Inhibitor Molecules
 
Number: 20080050744
 
Filed: Aug. 10, 2007
 
Lead Inventor: David Brown, Ambion (Applied Biosystems)
 
The invention “concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules,” the patent application’s abstract states. “Moreover, the … invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.”
 

 
Title: RNAi-Mediated Inhibition of Gremlin for Treatment of IOP-Related Conditions
 
Number: 20080051361
 
Filed: Aug. 24, 2007
 
Lead Inventor: Jon Chatterton, Alcon
 
According to the patent application’s abstract, the invention comprises “RNA interference …for [the] inhibition of gremlin in intraocular pressure-related conditions, including ocular hypertension and glaucoma such as normal tension glaucoma and open-angle glaucoma.”

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.